In late January, the Pharmaceutical Research and Manufacturers of America (PhRMA) launched a national, multi-year advertising and public affairs campaign on behalf of America’s biopharmaceutical companies, including AMAG Pharmaceuticals. The GOBOLDLY campaign will highlight the important contribution of our industry and employees to advance science that helps tackle serious health conditions facing patients in… More

Six Principles that Guide AMAG’s Promise to Patients and Families October 27, 2016 | AMAG News BY WILLIAM K. HEIDEN, CEO OF AMAG PHARMACEUTICALS It’s been hard to miss some recent negative headlines about the pharmaceutical industry. Drug pricing is once again in the news, and some difficult-to-defend situations are fueling some of the current… More

Every year in the United States, more than half a million babies are born too soon. Medical research supported by the March of Dimes is helping to improve babies’ chances of being born healthy and staying healthy. The mission of March of Dimes is to improve the health of babies by preventing birth defects, premature… More